PTC Inc has a consensus price target of $185.38 based on the ratings of 16 analysts. The high is $216 issued by Baird on May 2, 2024. The low is $138 issued by JP Morgan on December 14, 2021. The 3 most-recent analyst ratings were released by Mizuho, Citigroup, and Mizuho on June 4, 2024, May 2, 2024, and May 2, 2024, respectively. With an average price target of $192.33 between Mizuho, Citigroup, and Mizuho, there's an implied 10.66% upside for PTC Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/04/2024 | Buy Now | 9.32% | Mizuho | Matthew Broome | $200 → $190 | Downgrade | Buy → Neutral | Get Alert |
05/02/2024 | Buy Now | 7.59% | Citigroup | Tyler Radke | $195 → $187 | Maintains | Neutral | Get Alert |
05/02/2024 | Buy Now | 15.07% | Mizuho | Matthew Broome | $210 → $200 | Maintains | Buy | Get Alert |
05/02/2024 | Buy Now | 24.28% | Baird | Joe Vruwink | $210 → $216 | Maintains | Outperform | Get Alert |
04/12/2024 | Buy Now | 12.2% | Rosenblatt | Blair Abernethy | $195 → $195 | Maintains | Buy | Get Alert |
04/11/2024 | Buy Now | 23.71% | Barclays | Saket Kalia | $198 → $215 | Maintains | Overweight | Get Alert |
04/02/2024 | Buy Now | 20.83% | Baird | Joe Vruwink | → $210 | Maintains | Outperform | Get Alert |
02/01/2024 | Buy Now | 12.2% | Rosenblatt | Blair Abernethy | $166 → $195 | Maintains | Buy | Get Alert |
02/01/2024 | Buy Now | 16.23% | RBC Capital | Matthew Hedberg | → $202 | Reiterates | Outperform → Outperform | Get Alert |
02/01/2024 | Buy Now | 15.07% | BMO Capital | Daniel Jester | $195 → $200 | Maintains | Outperform | Get Alert |
02/01/2024 | Buy Now | 17.95% | Keybanc | Jason Celino | $190 → $205 | Maintains | Overweight | Get Alert |
02/01/2024 | Buy Now | 20.83% | Oppenheimer | Ken Wong | $190 → $210 | Maintains | Outperform | Get Alert |
02/01/2024 | Buy Now | 20.83% | Mizuho | Matthew Broome | $200 → $210 | Maintains | Buy | Get Alert |
01/23/2024 | Buy Now | 12.2% | BMO Capital | Daniel Jester | $184 → $195 | Maintains | Outperform | Get Alert |
01/19/2024 | Buy Now | 17.95% | Baird | Joe Vruwink | $200 → $205 | Maintains | Outperform | Get Alert |
01/12/2024 | Buy Now | 9.32% | Keybanc | Jason Celino | $177 → $190 | Maintains | Overweight | Get Alert |
01/09/2024 | Buy Now | 1.84% | Piper Sandler | Clarke Jeffries | $155 → $177 | Maintains | Neutral | Get Alert |
01/04/2024 | Buy Now | 15.07% | JP Morgan | Stephen Tusa | $130 → $200 | Upgrade | Neutral → Overweight | Get Alert |
12/11/2023 | Buy Now | 9.32% | Oppenheimer | Ken Wong | $165 → $190 | Maintains | Outperform | Get Alert |
11/02/2023 | Buy Now | -10.82% | Piper Sandler | Clarke Jeffries | $150 → $155 | Reiterates | Neutral → Neutral | Get Alert |
10/30/2023 | Buy Now | -5.06% | Oppenheimer | Ken Wong | → $165 | Upgrade | Perform → Outperform | Get Alert |
07/28/2023 | Buy Now | 3.57% | Mizuho | Matthew Broome | $170 → $180 | Maintains | Buy | Get Alert |
07/27/2023 | Buy Now | 0.69% | RBC Capital | Matthew Hedberg | $165 → $175 | Maintains | Outperform | Get Alert |
07/27/2023 | Buy Now | -4.49% | Barclays | Saket Kalia | $163 → $166 | Maintains | Overweight | Get Alert |
07/27/2023 | Buy Now | -13.69% | Piper Sandler | Clarke Jeffries | → $150 | Reiterates | Neutral → Neutral | Get Alert |
07/27/2023 | Buy Now | 1.84% | Keybanc | Jason Celino | $160 → $177 | Maintains | Overweight | Get Alert |
07/25/2023 | Buy Now | -14.84% | Rosenblatt | Blair Abernethy | → $148 | Reiterates | Buy → Buy | Get Alert |
07/24/2023 | Buy Now | -5.06% | RBC Capital | Matthew Hedberg | $158 → $165 | Maintains | Outperform | Get Alert |
07/14/2023 | Buy Now | -6.21% | Barclays | Saket Kalia | $152 → $163 | Maintains | Overweight | Get Alert |
06/21/2023 | Buy Now | -13.12% | Stifel | Adam Borg | → $151 | Reiterates | Buy → Buy | Get Alert |
06/14/2023 | Buy Now | -13.69% | Piper Sandler | Clarke Jeffries | → $150 | Initiates | → Neutral | Get Alert |
05/24/2023 | Buy Now | -4.49% | BMO Capital | Daniel Jester | → $166 | Initiates | → Outperform | Get Alert |
05/17/2023 | Buy Now | -2.19% | Mizuho | Matthew Broome | $165 → $170 | Maintains | Buy | Get Alert |
05/17/2023 | Buy Now | -9.09% | RBC Capital | Matthew Hedberg | → $158 | Reiterates | Outperform → Outperform | Get Alert |
05/17/2023 | Buy Now | -14.84% | Rosenblatt | Blair Abernethy | → $148 | Reiterates | Buy → Buy | Get Alert |
04/27/2023 | Buy Now | -9.09% | RBC Capital | Matthew Hedberg | $155 → $158 | Maintains | Outperform | Get Alert |
04/27/2023 | Buy Now | -12.54% | Barclays | Saket Kalia | $150 → $152 | Maintains | Overweight | Get Alert |
04/24/2023 | Buy Now | -19.45% | Citigroup | Tyler Radke | $147 → $140 | Maintains | Neutral | Get Alert |
04/14/2023 | Buy Now | -14.84% | Rosenblatt | Blair Abernethy | → $148 | Reiterates | → Buy | Get Alert |
02/02/2023 | Buy Now | -2.19% | Loop Capital | Yun Kim | $160 → $170 | Maintains | Buy | Get Alert |
02/02/2023 | Buy Now | -25.2% | JP Morgan | Stephen Tusa | $128 → $130 | Maintains | Neutral | Get Alert |
02/02/2023 | Buy Now | -5.06% | Mizuho | Matthew Broome | $155 → $165 | Maintains | Buy | Get Alert |
02/02/2023 | Buy Now | -13.69% | Barclays | Saket Kalia | $144 → $150 | Maintains | Overweight | Get Alert |
02/02/2023 | Buy Now | -14.84% | Rosenblatt | Blair Abernethy | $142 → $148 | Maintains | Buy | Get Alert |
02/02/2023 | Buy Now | -7.94% | Keybanc | Jason Celino | $155 → $160 | Maintains | Overweight | Get Alert |
01/30/2023 | Buy Now | -10.82% | RBC Capital | Matthew Hedberg | $140 → $155 | Maintains | Outperform | Get Alert |
01/27/2023 | Buy Now | -15.42% | Citigroup | Tyler Radke | $135 → $147 | Maintains | Neutral | Get Alert |
01/26/2023 | Buy Now | -5.06% | Baird | Joe Vruwink | $150 → $165 | Maintains | Outperform | Get Alert |
01/23/2023 | Buy Now | -10.82% | Keybanc | Jason Celino | → $155 | Upgrade | Sector Weight → Overweight | Get Alert |
01/11/2023 | Buy Now | -17.15% | Barclays | Saket Kalia | $148 → $144 | Maintains | Overweight | Get Alert |
01/11/2023 | Buy Now | -10.82% | Berenberg | Nay Soe Naing | → $155 | Initiates | → Buy | Get Alert |
01/05/2023 | Buy Now | -18.3% | Rosenblatt | Blair Abernethy | $138 → $142 | Maintains | Buy | Get Alert |
11/18/2022 | Buy Now | -10.82% | Mizuho | Matthew Broome | $135 → $155 | Maintains | Buy | Get Alert |
11/17/2022 | Buy Now | -14.84% | Barclays | Saket Kalia | $135 → $148 | Maintains | Overweight | Get Alert |
11/03/2022 | Buy Now | -19.45% | RBC Capital | Matthew Hedberg | $135 → $140 | Maintains | Outperform | Get Alert |
11/03/2022 | Buy Now | -20.6% | Rosenblatt | Blair Abernethy | $146 → $138 | Maintains | Buy | Get Alert |
10/24/2022 | Buy Now | -17.15% | Baird | Joe Vruwink | $153 → $144 | Maintains | Outperform | Get Alert |
09/19/2022 | Buy Now | -26.35% | JP Morgan | Stephen Tusa | → $128 | Reinstates | → Neutral | Get Alert |
08/17/2022 | Buy Now | -10.82% | Wolfe Research | Gal Munda | → $155 | Initiates | → Outperform | Get Alert |
07/28/2022 | Buy Now | -22.32% | RBC Capital | Matthew Hedberg | $130 → $135 | Maintains | Outperform | Get Alert |
07/28/2022 | Buy Now | -25.2% | Mizuho | Matthew Broome | $120 → $130 | Maintains | Buy | Get Alert |
07/27/2022 | Buy Now | — | Oppenheimer | Ken Wong | — | Initiates | → Perform | Get Alert |
07/21/2022 | Buy Now | -16% | Rosenblatt | Blair Abernethy | $156 → $146 | Maintains | Buy | Get Alert |
07/19/2022 | Buy Now | -30.96% | Mizuho | Matthew Broome | $135 → $120 | Maintains | Buy | Get Alert |
04/28/2022 | Buy Now | -30.96% | Barclays | Saket Kalia | $141 → $120 | Maintains | Overweight | Get Alert |
04/28/2022 | Buy Now | -22.32% | Mizuho | Matthew Broome | $125 → $135 | Maintains | Buy | Get Alert |
04/25/2022 | Buy Now | -25.2% | RBC Capital | Matthew Hedberg | $150 → $130 | Maintains | Outperform | Get Alert |
12/14/2021 | Buy Now | -20.6% | JP Morgan | Sterling Auty | — | Downgrade | Overweight → Neutral | Get Alert |
11/04/2021 | Buy Now | -2.19% | Rosenblatt | Blair Abernethy | — | Maintains | Buy | Get Alert |
10/18/2021 | Buy Now | -5.06% | Mizuho | Matthew Broome | — | Maintains | Buy | Get Alert |
10/13/2021 | Buy Now | -14.27% | Barclays | Saket Kalia | — | Maintains | Overweight | Get Alert |
The latest price target for PTC (NASDAQ:PTC) was reported by Mizuho on June 4, 2024. The analyst firm set a price target for $190.00 expecting PTC to rise to within 12 months (a possible 9.32% upside). 22 analyst firms have reported ratings in the last year.
The latest analyst rating for PTC (NASDAQ:PTC) was provided by Mizuho, and PTC downgraded their neutral rating.
The last upgrade for PTC Inc happened on January 4, 2024 when JP Morgan raised their price target to $200. JP Morgan previously had a neutral for PTC Inc.
The last downgrade for PTC Inc happened on June 4, 2024 when Mizuho changed their price target from $200 to $190 for PTC Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PTC, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PTC was filed on June 4, 2024 so you should expect the next rating to be made available sometime around June 4, 2025.
While ratings are subjective and will change, the latest PTC (PTC) rating was a downgraded with a price target of $200.00 to $190.00. The current price PTC (PTC) is trading at is $173.80, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.